| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.26 | 5e-09 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.25 | 9e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.17 | 0.0005 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.086 | 0.08 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.074 | 0.1 |